D. Bhattacharya, J. Mecsas, and L. T. Hu, Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestis, Vaccine, vol.28, pp.7683-7689, 2010.

T. Blisnick, P. Ave, M. Huerre, E. Carniel, and C. E. Demeure, Oral vaccination against bubonic plague using a live avirulent Yersinia pseudotuberculosis strain, Infect Immun, vol.76, pp.3808-3816, 2008.
URL : https://hal.archives-ouvertes.fr/pasteur-02075711

F. Bowe, P. O-gaora, D. Maskell, M. Cafferkey, and G. Dougan, Virulence, Persistence, and Immunogenicity of Yersinia enterocolitica 0:8 aroA Mutants, Infect Immun, vol.57, pp.3234-3236, 1989.

J. Boyer, C. Sofer-podesta, J. Ang, N. Hackett, M. Chiuchiolo et al., Protective Immunity Against a Lethal Respiratory Yersinia pestis Challenge Induced by V Antigen or the F1 Capsular Antigen Incorporated into the Adenovirus Capsid, 2010.

C. G. Branger, J. D. Fetherston, R. D. Perry, and R. Curtiss, Oral vaccination with different antigens from Yersinia pestis KIM delivered by live attenuated Salmonella typhimurium elicits a protective immune response against plague, Adv Exp Med Biol, vol.603, pp.387-399, 2007.

C. G. Branger, W. Sun, A. Torres-escobar, R. Perry, K. L. Roland et al., Evaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challenge, Vaccine, vol.29, pp.274-282, 2010.

C. G. Branger, A. Torres-escobar, W. Sun, R. Perry, J. Fetherston et al., Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonella enterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocolitica, Vaccine, vol.27, pp.5363-5370, 2009.

J. N. Brewoo, T. D. Powell, D. T. Stinchcomb, and J. E. Osorio, Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice, Vaccine, vol.28, pp.5891-5899, 2010.

I. E. Brodsky, N. W. Palm, S. Sadanand, M. B. Ryndak, F. S. Sutterwala et al., A Yersinia Effector Protein Promotes Virulence by Preventing Inflammasome Recognition of the Type III Secretion System, Cell Host Microbe, vol.7, pp.376-387, 2010.

S. S. Bubeck and P. H. Dube, Yersinia pestis CO92 Delta yopH is a potent live, attenuated plague vaccine, Clin Vaccine Immunol, vol.14, pp.1235-1238, 2007.

T. W. Burrows, An Antigen determining Virulence in Pasteurella pestis, Nature, vol.177, pp.426-427, 1956.

T. W. Burrows, Virulence of "Pasteurella pestis" and immunity to plague, Ergebnisse der Mikrobiologie Immunitätsforschung und Experimentellen Therapie, vol.37, pp.59-113, 1963.

T. W. Burrows and G. A. Bacon, The effects of loss of different virulence determinants on the virulence and immunogenicity of strains of Pasteurella pestis, Brit J Exp Pathol, vol.39, pp.278-291, 1958.

L. N. Calhoun and Y. M. Kwon, Salmonella-based plague vaccines for bioterrorism, J Microbiol Immunol Infect, vol.39, pp.92-97, 2006.

E. Carniel, The Yersinia high-pathogenicity island: an iron-uptake island, Microbiol Infect, vol.3, pp.561-569, 2001.

K. W. Carr, D. G. Heath, and A. M. Friedlander, Antiphagocytic effect of F1 capsular protein of Yersinia pestis. Abstracts of the General Meeting of the, p.96, 1997.

J. S. Cathelyn, S. D. Crosby, W. W. Lathem, W. E. Goldman, and V. L. Miller, RovA, a global regulator of Yersinia pestis, specifically required for bubonic plague, Proc Natl Acad Sci, vol.103, pp.13514-13519, 2006.

P. Chain, W. Regala, L. Marieiro, B. Souza, J. Elliott et al., Whole genome sequencing of Yersinia pseudotuberculosis: Examining pathogen evolution among the recently emerged Yersinia, Abstracts of the General Meeting of the American Society for Microbiology, vol.102, 2002.

A. Chattopadhyay, S. Park, G. Delmas, R. Suresh, S. Senina et al., Single-dose, virus-vectored vaccine protection against Yersinia pestis challenge: CD4+ cells are required at the time of challenge for optimal protection, Vaccine, vol.26, pp.6329-6337, 2008.

M. J. Chiuchiolo, J. L. Boyer, A. Krause, S. Senina, N. R. Hackett et al., Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen, J Infect Dis, vol.194, pp.1249-1257, 2006.

C. A. Cornelius, L. E. Quenee, D. Elli, N. A. Ciletti, and O. Schneewind, Yersinia pestis IS1541 transposition provides for escape from plague immunity, Infect Immun, vol.77, pp.1807-1816, 2009.

C. Cowan, A. V. Philipovskiy, C. R. Wulff-strobel, Z. Ye, and S. C. Straley, Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis, Infect Immun, vol.73, pp.6127-6137, 2005.

C. Daniel, F. Sebbane, S. Poiret, D. Goudercourt, J. Dewulf et al., Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV, Vaccine, vol.27, pp.1141-1144, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00368381

K. J. Davis, D. L. Fritz, M. L. Pitt, S. L. Welkos, P. L. Worsham et al., Pathology of experimental pneumonic plague produced by fraction 1-positive and fraction 1-negative Yersinia pestis in African green monkeys (Cercopithecus aethiops), Arch Pathol Lab Med, vol.120, pp.156-163, 1996.

D. T. Dennis, Plague as a biological weapon, Bioterrorism and Infectious Agents: A New Dilemma for 21st Century, pp.37-70, 2005.

R. W. Depaolo, F. M. Tang, I. Kim, M. Han, N. Levin et al., Toll-Like Receptor 6 Drives Differentiation of Tolerogenic Dendritic Cells and Contributes to LcrV-Mediated Plague Pathogenesis, Cell Host & Microbe, vol.4, pp.350-361, 2008.

D. A. Dilts, I. Riesenfeld-orn, J. P. Fulginiti, E. Ekwall, C. Granert et al., Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity, Vaccine, vol.18, pp.1473-1484, 2000.

N. Dorrell, S. R. Li, P. H. Everest, G. Dougan, and B. W. Wren, Construction and Characterisation Of a Yersinia enterocolitica O-8 Ompr Mutant, FEMS Microbiol Lett, vol.165, pp.145-151, 1998.

T. J. Easterbrook, K. Reddin, A. Robinson, and N. Modi, Studies on the immunogenicity of the Pla protein from Yersinia pestis, Yersiniosis : Present and Future, pp.214-215, 1995.

S. J. Elvin and E. D. Williamson, The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses, Microb Pathog, vol.29, pp.223-230, 2000.

S. J. Elvin and E. D. Williamson, Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague, Microb Pathog, vol.37, pp.177-184, 2004.

A. Embry, X. Meng, A. Cantwell, P. H. Dube, and Y. Xiang, Enhancement of immune response to an antigen delivered by vaccinia virus by displaying the antigen on the surface of intracellular mature virion, Vaccine, vol.29, pp.5331-5339, 2011.

S. E. Erfurth, S. Grobner, U. Kramer, D. S. Gunst, I. Soldanova et al., Yersinia enterocolitica induces apoptosis and inhibits surface molecule expression and cytokine production in murine dendritic cells, Infect Immun, vol.72, pp.7045-7054, 2004.

V. A. Feodorova and M. J. Corbel, Prospects for new plague vaccines, Expert Rev Vaccines, vol.8, pp.1721-1738, 2009.

V. A. Feodorova, L. N. Pan'kina, E. P. Savostina, O. S. Kuznetsov, N. P. Konnov et al., , 2009.

, Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens, Vaccine, vol.27, pp.2240-2250

V. A. Feodorova, L. N. Pan'kina, E. P. Savostina, L. V. Sayapina, V. L. Motin et al., A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs, Vaccine, vol.25, pp.7620-7628, 2007.

Y. Flashner, E. Mamroud, A. Tidhar, R. Ber, M. Aftalion et al., Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates, Infect Immun, vol.72, pp.908-915, 2004.

A. M. Friedlander, S. L. Welkos, P. L. Worsham, G. P. Andrews, D. G. Heath et al., Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis, Clin Infect Dis, vol.21, pp.178-181, 1995.

E. M. Galvan, M. A. Lasaro, and D. M. Schifferli, Capsular antigen fraction 1 and pla modulate the susceptibility of Yersinia pestis to pulmonary antimicrobial peptides such as cathelicidin, Infect Immun, vol.76, pp.1456-1464, 2008.

H. S. Garmory, D. Freeman, K. A. Brown, and R. W. Titball, Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen, Vaccine, vol.22, pp.947-957, 2004.

H. S. Garmory, K. F. Griffin, K. A. Brown, and R. W. Titball, Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague, Vaccine, vol.21, pp.3051-3057, 2003.

G. Girard, Immunity in Plague. Acquisitions Supplied by 30 Years of Work on the "Pasteurella Pestis Ev" (Girard and Robic) Strain, Biol Med, vol.52, pp.631-731, 1963.

M. Green, D. Rogers, P. Russell, A. J. Stagg, D. L. Bell et al., The SCID/Beige mouse as a model to investigate protection against Yersinia pestis, FEMS Immunol Med Microbiol, vol.23, pp.107-113, 1999.

K. Griffin, J. Hill, K. Murray, S. Leary, R. Titball et al., Protective efficacies of the V antigen variants in Yersinia, 7th International Congress on Yersinia, p.35, 1998.

A. Guiyoule, B. Rasoamanana, C. Buchrieser, P. Michel, S. Chanteau et al., , 1997.

, Recent Emergence Of New Variants Of Yersinia Pestis In Madagascar, J Clin Microbiol, vol.35, pp.2826-2833

D. G. Heath, J. Anderson, G. W. Welkos, S. L. Andrews, G. P. Friedlander et al., A recombinant capsular F1-V antigen fusion protein vaccine protects against experimental bubonic and pneumonic plague, Vaccine, vol.97, pp.197-200, 1997.

J. Heesemann, A. Sing, and K. Trulzsch, Yersinia's stratagem: targeting innate and adaptive immune defense, Curr Opin Microbiol, vol.9, pp.55-61, 2006.

J. Hill, C. Copse, S. Leary, A. J. Stagg, E. D. Williamson et al., Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis, Infect Immun, vol.71, pp.2234-2238, 2003.

E. L. Hohmann, C. A. Oletta, and S. I. Miller, Evaluation of a phoP/phoQ-deleted, aroAdeleted live oral Salmonella typhi vaccine strain in human volunteers, Vaccine, vol.14, pp.19-24, 1996.

A. Holmstrom, J. Pettersson, R. Rosqvist, S. Hakansson, F. Tafazoli et al., YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane, Mol Microbiol, vol.24, pp.73-91, 1997.

D. Huang, C. Y. Chen, Z. Ali, L. Shao, L. Shen et al., Antigen-specific Vgamma2Vdelta2 T effector cells confer homeostatic protection against pneumonic plaque lesions, Proc Natl Acad Sci U S A, vol.106, pp.7553-7558, 2009.

E. I. Igwe, H. Russmann, A. Roggenkamp, A. Noll, I. B. Autenrieth et al., Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica, Infect Immun, vol.67, pp.5500-5507, 1999.

M. I. Ivanov, B. L. Noel, R. Rampersaud, P. Mena, J. L. Benach et al., Vaccination of Mice with a Yop Translocon Complex Elicits Antibodies That Are Protective against Infection with F1(-) Yersinia pestis, Infect Immun, vol.76, pp.5181-5190, 2008.

S. M. Julio, D. M. Heithoff, D. Provenzano, K. E. Klose, R. L. Sinsheimer et al., DNA adenine methylase is essential for viability and plays a role in the pathogenesis of Yersinia pseudotuberculosis and Vibrio cholerae, Infect Immun, vol.69, pp.7610-7615, 2001.

S. A. Khader, S. L. Gaffen, and J. K. Kolls, Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa, Mucosal Immunol, vol.2, pp.403-411, 2009.

M. Kukkonen, K. Lahteenmaki, M. Suomalainen, N. Kalkkinen, L. Emody et al., Protein regions important for plasminogen activation and inactivation of alpha(2)-antiplasmin in the surface protease Pla of Yersinia pestis, Mol Microbiol, vol.40, pp.1097-1111, 2001.

L. W. Kummer, F. M. Szaba, M. A. Parent, J. J. Adamovicz, J. Hill et al., Antibodies and cytokines independently protect against pneumonic plague, Vaccine, vol.26, pp.6901-6907, 2008.

M. O. Lasaro and H. C. Ertl, New insights on adenovirus as vaccine vectors, Mol Ther, vol.17, pp.1333-1339, 2009.

W. W. Lathem, P. A. Price, V. L. Miller, and W. E. Goldman, A plasminogen-activating protease specifically controls the development of primary pneumonic plague, Science, vol.315, pp.509-513, 2007.

S. E. Leary, K. F. Griffin, E. E. Galyov, J. Hewer, E. D. Williamson et al., Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague, Microb Pathog, vol.26, pp.159-169, 1999.

B. Li, Y. Guo, Z. Guo, Y. Liang, Z. Zhu et al., , 2008.

, Serologic survey of the sentinel animals for plague surveillance and screening for complementary diagnostic markers to F1 antigen by protein microarray, Am J Trop Med Hyg, vol.79, pp.799-802

B. Li, L. X. Jiang, Q. F. Song, J. X. Yang, Z. L. Chen et al., Protein Microarray for profiling antibody responses to Yersinia pestis live vaccine, Infect Immun, vol.73, pp.3734-3739, 2005.

B. Li, D. Zhou, Z. Wang, Z. Song, H. Wang et al., Antibody profiling in plague patients by protein microarray, Microbes Infect, vol.10, pp.45-51, 2008.

B. Li, L. Zhou, J. Guo, X. Wang, B. Ni et al., Highthroughput identification of new protective antigens from a Yersinia pestis live vaccine by enzyme-linked immunospot assay, Infect Immun, vol.77, pp.4356-4361, 2009.

J. S. Lin, L. W. Kummer, F. M. Szaba, and S. T. Smiley, IL-17 contributes to cellmediated defense against pulmonary Yersinia pestis infection, J Immunol, vol.186, pp.1675-1684, 2011.

Y. Lin, S. R. Slight, and S. A. Khader, Th17 cytokines and vaccine-induced immunity, Semin Immunopathol, vol.32, pp.79-90, 2010.

L. E. Lindler, M. S. Klempner, and S. C. Straley, Yersinia pestis pH-6 Antigen -Genetic, Biochemical, and Virulence Characterization of a Protein Involved in the Pathogenesis of Bubonic Plague, Infect Immun, vol.58, pp.2569-2577, 1990.

F. Z. Liu, H. Q. Chen, E. M. Galvan, M. A. Lasaro, and D. M. Schifferli, Effects of Psa and F1 on the adhesive and invasive interactions of Yersinia pestis with human respiratory tract epithelial cells, Infect Immun, vol.74, pp.5636-5644, 2006.

W. T. Liu, H. L. Hsu, C. C. Liang, C. C. Chuang, H. C. Lin et al., A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen, FEMS Immunol Med Microbiol, vol.51, pp.58-69, 2007.

M. M. Marketon, R. W. Depaolo, K. L. Debord, B. Jabri, and O. Schneewind, Plague Bacteria Target Immune Cells During Infection, Science, pp.1-3, 2005.

J. S. Matson, K. A. Durick, D. S. Bradley, and M. L. Nilles, Immunization of mice with YscF provides protection from Yersinia pestis infections, BMC Microbiol, vol.5, p.38, 2005.

J. S. Mencher, S. R. Smith, T. D. Powell, D. T. Stinchcomb, J. E. Osorio et al., Protection of black-tailed prairie dogs (Cynomys ludovicianus) against plague after voluntary consumption of baits containing recombinant raccoon poxvirus vaccine, Infect Immun, vol.72, pp.5502-5505, 2004.

K. F. Meyer, Effectiveness of live or killed plague vaccines in man, Bull Wld Hlth Org, vol.42, pp.653-666, 1970.

K. F. Meyer, J. A. Hightower, and F. R. Mccrumb, Plague immunization. VI. Vaccination with the fraction I antigen of Yersinia pestis, J Infect Dis, vol.129, pp.41-45, 1974.

K. F. Meyer, G. Smith, L. Foster, M. Brookman, and M. Sung, Live, attenuated Yersinia pestis vaccine: virulent in nonhuman primates, harmless to guinea pigs, J Infect Dis, vol.129, pp.85-97, 1974.

H. H. Mollaret, Fifteen centuries of yersiniosis, pp.1-4, 1995.

S. W. Montminy, N. Khan, S. Mcgrath, M. J. Walkowicz, F. Sharp et al., Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response, Nature Immunol, 2006.

M. Morton, H. S. Garmory, S. D. Perkins, A. M. O'dowd, K. F. Griffin et al., A Salmonella enterica serovar Typhi vaccine expressing Yersinia pestis F1 antigen on its surface provides protection against plague in mice, Vaccine, vol.22, pp.2524-2532, 2004.

R. Nakajima and R. R. Brubaker, Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha, Infect Immun, vol.61, pp.23-31, 1993.

Y. A. Nedialkov, V. L. Motin, and R. R. Brubaker, Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide: Amplification of interleukin-10, Infect Immun, vol.65, pp.1196-1203, 1997.

N. A. Okan, P. Mena, J. L. Benach, J. B. Bliska, and A. W. Karzai, smpB-ssrA Mutant of Yersinia pestis Functions As a Live Attenuated Vaccine to Protect Mice Against Pulmonary Plague Infection, Infect Immun, vol.78, pp.1284-1293, 2010.

J. E. Osorio, T. D. Powell, R. S. Frank, K. Moss, E. J. Haanes et al., Recombinant raccoon pox vaccine protects mice against lethal plague, Vaccine, vol.21, pp.1232-1238, 2003.

K. A. Overheim, R. W. Depaolo, K. L. Debord, E. M. Morrin, D. M. Anderson et al., LcrV plague vaccine with altered immunomodulatory properties, Infect Immun, vol.73, pp.5152-5159, 2005.

P. C. Oyston, G. Mellado-sanchez, M. F. Pasetti, J. P. Nataro, R. W. Titball et al.,

, A Yersinia pestis guaBA mutant is attenuated in virulence and provides protection against plague in a mouse model of infection

P. C. Oyston, P. Russell, E. D. Williamson, and R. W. Titball, An aroA mutant of Yersinia pestis is attenuated in guinea-pigs, but virulent in mice, Microbiology-Uk, vol.142, pp.1847-1853, 1996.

P. C. Oyston, E. D. Williamson, S. E. Leary, S. M. Eley, K. F. Griffin et al., Immunization with live recombinant Salmonella typhimurium aroA producing F1 antigen protects against plague, Infect Immun, vol.63, pp.563-568, 1995.

A. Palin, A. Chattopadhyay, S. Park, G. Delmas, R. Suresh et al., An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge, Vaccine, vol.25, pp.741-750, 2007.

M. A. Parent, K. N. Berggren, L. W. Kummer, L. B. Wilhelm, F. M. Szaba et al., Cell-mediated protection against pulmonary Yersinia pestis infection, Infect Immun, vol.73, pp.7304-7310, 2005.

M. A. Parent, L. B. Wilhelm, L. W. Kummer, F. M. Szaba, I. K. Mullarky et al., Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection, Infect Immun, vol.74, pp.3381-3386, 2006.

M. F. Pasetti, T. E. Pickett, M. M. Levine, and M. B. Sztein, A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model, Vaccine, vol.18, pp.3208-3213, 2000.

P. P. Pastoret and B. Brochier, The development and use of a vaccinia-rabies recombinant oral vaccine for the control of wildlife rabies; a link between Jenner and Pasteur, Epidemiol Infect, vol.116, pp.235-240, 1996.

P. P. Pastoret and B. Brochier, Epidemiology and control of fox rabies in Europe, Vaccine, vol.17, pp.1750-1754, 1999.

F. E. Payne, A. Larson, D. L. Walker, L. Foster, and K. F. Meyer, Studies on immunization against plague. IX. The effect of cortisone on mouse resistance to attenuated of Pasteurella pestis, J Infect Dis, vol.96, pp.168-173, 1955.

A. V. Philipovskiy, C. Cowan, C. R. Wulff-strobel, S. H. Burnett, E. J. Kerschen et al., Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis, Infect Immun, vol.73, pp.1532-1542, 2005.

A. V. Philipovskiy and S. T. Smiley, Vaccination with live Yersinia pestis primes CD4 an CD8 T cells that synergistically protect against lethal pulmonary Yersinia pestis infection, Infect Immun, vol.75, pp.878-885, 2007.

S. A. Plotkin, Vaccines: correlates of vaccine-induced immunity, Clin Infect Dis, vol.47, pp.401-409, 2008.

F. Poelma and G. Voogt, Immunisierung von Affen gegen Pasteurella pseudotuberculosis mit einer Totvakzine aus virulenten Bakterienstämme, XI International Symposium Erkrankungen der Zootiere (Zagreb), 1969.

K. Pouliot, N. Pan, S. X. Wang, S. Lu, E. Lien et al., Evaluation of the role of LcrV-Toll-Like receptor 2-mediated immunomodulation in the virulence of Yersinia pestis, Infect Immun, vol.75, pp.3571-3580, 2007.

L. E. Quenee, C. A. Cornelius, N. A. Ciletti, D. Elli, and O. Schneewind, Yersinia pestis caf1 variants and the limits of plague vaccine protection, Infect Immun, vol.76, pp.2025-2036, 2008.

B. Quintard, T. Petit, N. Ruvoen, E. Carniel, and C. E. Demeure, Efficacy of an oral live vaccine for veterinary use against pseudotuberculosis, Comp Immunol Microbiol Infect Dis, vol.33, pp.59-65, 2009.
URL : https://hal.archives-ouvertes.fr/pasteur-02075702

R. T. Robinson, S. A. Khader, R. M. Locksley, E. Lien, S. T. Smiley et al., , 2008.

, Yersinia pestis evades TLR4-dependent induction of IL-12(p40)(2) by dendritic cells and subsequent cell migration, J Immunol, vol.181, pp.5560-5567

V. L. Robinson, P. C. Oyston, and R. W. Titball, A dam mutant of Yersinia pestis is attenuated and induces protection against plague, FEMS Microbiol Lett, vol.252, pp.251-256, 2005.

T. E. Rocke, K. P. Iams, S. Dawe, S. R. Smith, J. L. Williamson et al., Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis), Vaccine, vol.28, pp.338-344, 2009.

T. E. Rocke, N. Pussini, S. R. Smith, J. Williamson, B. Powell et al., Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (Cynomys ludovicianus), Vector Borne Zoonotic Dis, vol.10, pp.53-58, 2010.

A. Roggenkamp, A. M. Geiger, L. Leitritz, A. Kessler, and J. Heesemann, Passive Immunity to Infection With Yersinia Spp Mediated By Anti-Recombinant V Antigen Is Dependent On Polymorphism Of V Antigen, Infect Immun, vol.65, pp.446-451, 1997.

P. Russel, S. M. Eley, S. E. Hibbs, R. J. Manchee, A. J. Stagg et al., A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model, Vaccine, vol.13, pp.1551-1556, 1995.

R. Salerno-goncalves and M. B. Sztein, Cell-mediated immunity and the challenges for vaccine development, Trends Microbiol, vol.14, pp.536-542, 2006.

F. Sebbane, C. O. Jarrett, D. Gardner, D. Long, and B. J. Hinnebusch, Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague, Proc Natl Acad Sci, vol.103, pp.5526-5530, 2006.

M. Simonet, P. Berche, D. Mazigh, and M. Veron, Protection against Yersinia infection induced by non-virulence-plasmid-encoded antigens, J Med Microbiol, vol.20, pp.225-231, 1985.

W. J. Simpson, R. E. Thomas, and T. G. Schwan, Recombinant Capsular Antigen (Fraction-1) from Yersinia pestis Induces a Protective Antibody Response in BALB/c Mice, Am J Trop Med Hyg, vol.43, pp.389-396, 1990.

A. Sing, D. Reithmeier-rost, K. Granfors, J. Hill, A. Roggenkamp et al., , 2005.

, A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence, Proc Natl Acad Sci, vol.102, pp.16049-16054

O. A. Sodeinde, Y. V. Subrahmanyam, K. Stark, T. Quan, Y. D. Bao et al., A surface protease and the invasive character of plague, Science, vol.258, pp.1004-1007, 1992.

C. Sofer-podesta, J. Ang, N. R. Hackett, S. Senina, D. Perlin et al., Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge, Infect Immun, vol.77, pp.1561-1568, 2009.

W. Swietnicki, B. S. Powell, and J. Goodin, Yersinia pestis Yop secretion protein F: Purification, characterization, and protective efficacy against bubonic plague, Protein Expr Purif, vol.42, pp.166-172, 2005.

F. M. Szaba, L. W. Kummer, L. B. Wilhelm, J. S. Lin, M. A. Parent et al., D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague, Infect Immun, vol.77, pp.4295-4304, 2009.

C. O. Tacket, M. B. Sztein, G. A. Losonsky, S. S. Wasserman, J. P. Nataro et al., Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans, Infect Immun, vol.65, pp.452-456, 1997.

V. L. Taylor, R. W. Titball, and P. C. Oyston, Oral immunization with a dam mutant of Yersinia pseudotuberculosis protects against plague, Microbiology, vol.151, pp.1919-1926, 2005.

E. A. Thornton and G. R. Smith, Oral vaccination against pseudotuberculosis, Vaccine, vol.14, pp.977-981, 1996.

A. Tidhar, Y. Flashner, S. Cohen, Y. Levi, A. Zauberman et al., The NlpD lipoprotein is a novel Yersinia pestis virulence factor essential for the development of plague, PLoS One, vol.4, p.7023, 2009.

R. W. Titball, A. M. Howells, P. C. Oyston, and E. D. Williamson, Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague, Infect Immun, vol.65, 1926.

R. W. Titball and E. D. Williamson, Vaccination against bubonic and pneumonic plague, Vaccine, vol.19, pp.4175-4184, 2001.

A. Torres-escobar, M. D. Juarez-rodriguez, B. M. Gunn, C. G. Branger, S. A. Tinge et al., Fine-Tuning Synthesis of Yersinia pestis LcrV from Runaway-Like Replication Balanced-Lethal Plasmid in a Salmonella enterica Serovar Typhimurium Vaccine Induces Protection against a Lethal Y. pestis Challenge in Mice, Infect Immun, vol.78, pp.2529-2543, 2010.

J. K. Turner, J. L. Xu, R. I. Tapping, D. Van-duin, R. Medzhitov et al., Substrains of 129 Mice Are Resistant to Yersinia pestis KIM5: Implications for Interleukin-10-Deficient Mice, Trends Immunol, vol.77, pp.49-55, 2006.

B. Velan, E. Bar-haim, A. Zauberman, E. Mamroud, A. Shafferman et al., , 2006.

, Discordance in the Effects of Yersinia pestis on the Dendritic Cell Functions Manifested by Induction of Maturation and Paralysis of Migration, Infect Immun, vol.74, pp.6365-6376

G. I. Viboud and J. B. Bliska, Yersinia Outer Proteins: role in modulation of host cell signaling responses and pathogenesis, Annu Rev Microbiol, vol.59, pp.69-89, 2005.

A. Wake, H. Morita, W. , and M. , Mechanisms of long and short term immunity to plague, Immunology, vol.34, pp.1045-1052, 1978.

S. X. Wang, S. Joshi, I. Mboudjeka, F. J. Liu, T. F. Ling et al., , 2008.

, Relative immunogenicity and protection potential of candidate Yersinia Pestis antigens against lethal mucosal plague challenge in Balb/C mice, Vaccine, vol.26, pp.1664-1674

E. H. Weening, J. S. Cathelyn, G. Kaufman, M. B. Lawrenz, P. Price et al., The Dependence of the Yersinia pestis Capsule on Pathogenesis Is Influenced by the Mouse Background, Infect Immun, vol.79, pp.644-652, 2011.

S. Welkos, S. Norris, A. , and J. , Modified caspase-3 assay indicates correlation of caspase-3 activity with immunity of nonhuman primates to Yersinia pestis infection, Clin Vaccine Immunol, vol.15, pp.1134-1137, 2008.

S. L. Welkos, K. M. Davis, L. M. Pitt, P. L. Worsham, and A. M. Friedlander, Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis, pp.299-305, 1995.

E. D. Williamson, H. C. Flick-smith, C. Lebutt, C. A. Rowland, S. M. Jones et al., Human immune response to a plague vaccine comprising recombinant F1 and V antigens, Infect Immun, vol.73, pp.3598-3608, 2005.

C. C. Winter, W. B. Cherry, and M. D. Moody, An Unusual Strain of Pasteurella pestis Isolated from a Fatal Human Case of Plague, Bull Org Mond Santé Bull Wld Hlth Org, vol.23, pp.408-409, 1960.

P. Worsham and M. Hunter, Characterisation of pestoides F, an atypical strain of Yersinia pestis, Nederlands Tijdschrift voor Medische Microbiologie, p.34, 1998.

X. H. Yang, B. J. Hinnebusch, T. Trunkle, C. M. Bosio, Z. Y. Suo et al., Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague, J Immunol, vol.178, pp.1059-1067, 2007.

A. Zauberman, S. Cohen, Y. Levy, G. Halperin, S. Lazar et al., Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague, Vaccine, vol.26, pp.1616-1625, 2008.

A. Zauberman, A. Tidhar, Y. Levy, E. Bar-haim, G. Halperin et al., Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague, PLoS One, vol.4, p.5938, 2009.

D. S. Zhou, Y. P. Han, E. H. Dai, Y. J. Song, D. C. Pei et al., Defining the genome content of live plague vaccines by use of whole-genome DNA microarray, Vaccine, vol.22, pp.3367-3374, 2004.